slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 229,801-229,830
Pages 10,126
Rows per page 30
Component
229,801-229,830 of 303,780
12
The slide highlights a partnership-based supply chain and a proprietary onsite generator technology to mitigate risks associated with traditional cyclotron production.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
13
Highlights internal manufacturing readiness and scale.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
14
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
17
Includes a visual comparison between a 'cold' antibody and the 'hot' FPI-1434 conjugate.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
Includes medical imaging (SPECT/CT) comparing baseline vs. cold antibody intervention.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
Includes before/after PET-CT scan imagery.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
21
The chart shows a clear dose-dependent reduction in tumor volume compared to vehicle and cold antibody controls.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
23
Includes headshots, titles, key experience bullets, and a grid of company logos representing past experience.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Team1 hit
24
Includes a footnote explaining the pro forma cash calculation.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
25
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
26
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
01
Goldman Sachs | Results Presentation Deck | 25 slidesGoldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations 1 hit
02
The slide uses a visual connection between the firm's values (left) and its strategic pillars (right).Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a Venn diagram to show the intersection of two business units.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · Attention1 hit
07
The slide uses a split-chart approach to demonstrate the shift in business model composition.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
The slide uses a hierarchical structure to map high-level objectives to specific execution areas and final outcomes.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
Includes a table detailing the impact of specific items on pre-tax earnings, net earnings, EPS, and ROE.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Includes specific commentary on credit loss provisions and operating expense drivers.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
Includes comparative performance metrics against 3Q23 and 4Q22/2022.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
The table provides a breakdown of revenue by business line with period-over-period comparisons (vs 3Q23, vs 4Q22, vs 2022).Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
Includes detailed breakdown of revenue drivers and specific impairment impacts.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
Includes footnote references (7) throughout the slide.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
17
Includes a waterfall chart for historical principal investments rollforward.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
18
Includes a detailed financial table comparing 4Q23 and 2023 results against prior periods, alongside qualitative commentary on revenue and credit loss drivers.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
19
Includes a mix of stacked bar charts for segment trends and a detailed table for loan types.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
Includes data on firmwide loans, CRE-related and office-related exposures, and key performance metrics like delinquency and charge-off ratios.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
21
Includes a detailed financial table and a bar chart comparing the efficiency ratio between 2023 and 2022.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
22
Includes tables for Capital, Selected Balance Sheet Data, and Book Value, alongside a list of key highlights.Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
23
Goldman Sachs | Results Presentation Deck | 25 slidesGoldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations 1 hit